Abeo-HHC acetate
From Wikipedia, the free encyclopedia
Semi-synthetic derivative of THC
Pharmaceutical compound
| Identifiers | |
|---|---|
| |
| CAS Number | |
| Chemical and physical data | |
| Formula | C23H34O3 |
| Molar mass | 358.522 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Abeo-HHC acetate is a semi-synthetic derivative of tetrahydrocannabinol, first described in the 1980s. It is synthesised from delta-11-tetrahydrocannabinol, which can be made to undergo a ring expansion reaction via a hydrazone intermediate.[1][2] It is structurally similar to HHC-acetate except that the methylated cyclohexyl ring has been replaced by a cycloheptane.
References
- ↑ Srebnik M, Mechoulam R (1984). "Reactions of cannabinoid tosylhydrazones: Stereochemical aspects". Tetrahedron. 40 (19): 3839–3843. doi:10.1016/S0040-4020(01)88815-3.
- ↑ Ujváry I (June 2023). "Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review". Drug Testing and Analysis. 16 (2): 127–161. doi:10.1002/dta.3519. PMID 37269160. S2CID 259046522.
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |